Cost of Revenue in USD of scPharmaceuticals Inc. from Q1 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
scPharmaceuticals Inc. quarterly/annual Cost of Revenue history and change rate from Q1 2023 to Q2 2025.
  • scPharmaceuticals Inc. Cost of Revenue for the quarter ending June 30, 2025 was $5.01M, a 118% increase year-over-year.
  • scPharmaceuticals Inc. Cost of Revenue for the twelve months ending June 30, 2025 was $15.8M, a 127% increase year-over-year.
  • scPharmaceuticals Inc. annual Cost of Revenue for 2024 was $11.4M, a 198% increase from 2023.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

scPharmaceuticals Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $15.8M $5.01M +$2.71M +118% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $13M $3.47M +$1.69M +94.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $11.4M $3.97M +$2.19M +124% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-19
Q3 2024 $9.17M $3.31M +$2.23M +207% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $6.94M $2.3M +$1.95M +550% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $4.99M $1.79M +$1.18M +195% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q4 2023 $3.81M $1.77M Oct 1, 2023 Dec 31, 2023 10-K 2025-03-19
Q3 2023 $1.08M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $354K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $605K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14

scPharmaceuticals Inc. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $11.4M +$7.55M +198% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-19
2023 $3.81M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.